KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 158 filers reported holding KRYSTAL BIOTECH INC in Q4 2022. The put-call ratio across all filers is 6.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,344,828 | -0.8% | 46,092 | +0.3% | 1.80% | +9.8% |
Q2 2023 | $5,389,349 | +10.4% | 45,945 | -24.7% | 1.64% | +20.4% |
Q1 2023 | $4,883,660 | +37.3% | 61,000 | +35.6% | 1.36% | +24.0% |
Q4 2022 | $3,558,150 | +13.6% | 45,000 | 0.0% | 1.10% | +9.5% |
Q3 2022 | $3,132,000 | -93.0% | 45,000 | +1422.8% | 1.00% | +114.1% |
Q2 2022 | $45,000,000 | +3968.7% | 2,955 | -93.4% | 0.47% | +88.4% |
Q1 2022 | $1,106,000 | -64.9% | 45,000 | 0.0% | 0.25% | -64.5% |
Q4 2021 | $3,148,000 | – | 45,000 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |